J. Goudreau

发表

A call for transparent reporting to optimize the predictive value of preclinical research

S. Lazic, O. Steward, Story C. Landis, 2012, Nature.

Inosine to increase serum and cerebrospinal fluid urate in Parkinson disease: a randomized clinical trial.

J. Friedman, J. Carter, M. Beal, 2014, JAMA neurology.

Lack of D2 receptor mediated regulation of dopamine synthesis in A11 diencephalospinal neurons in male and female mice

J. Goudreau, S. S. Pappas, K. Lookingland, 2008, Brain Research.

Executive function in Parkinson’s disease: contributions of the dorsal frontostriatal pathways to action and motivation

M. Delgado, J. Goudreau, S. Ravizza, 2012, Cognitive, affective & behavioral neuroscience.

Periventricular-hypophysial dopaminergic neurons innervate the intermediate but not the neural lobe of the rat pituitary gland.

J. Goudreau, K. Lookingland, K. Moore, 1995, Neuroendocrinology.

BDNF rs6265 Variant Alters Outcomes with Levodopa in Early-Stage Parkinson’s Disease

J. Goudreau, K. Kieburtz, P. Auinger, 2020, Neurotherapeutics.

Opioid-mediated regulation of A11 diencephalospinal dopamine neurons: Pharmacological evidence of activation by morphine

J. Goudreau, S. S. Pappas, K. Lookingland, 2011, Neuropharmacology.

Choice of dopaminergic therapy among early, mild Parkinson disease subjects in North America

C. Christine, M. Aminoff, J. Goudreau, 2016, Journal of the Neurological Sciences.

Parkinson's disease severity and use of dopaminergic medications.

C. Christine, M. Aminoff, R. Zweig, 2015, Parkinsonism & related disorders.

Sex differences by design and outcome in the Safety of Urate Elevation in PD (SURE-PD) trial

J. Goudreau, C. Goetz, A. Rudolph, 2019, Neurology.

Complications during apnea testing in the determination of brain death: Predisposing factors

J. Goudreau, E. Wijdicks, S. F. Emery, 2000, Neurology.

Restoring pars intermedia dopamine concentrations and tyrosine hydroxylase expression levels with pergolide: evidence from horses with pituitary pars intermedia dysfunction

J. Goudreau, K. Lookingland, J. Patterson, 2020, BMC Veterinary Research.

No pathogenic mutations in the persyn gene in Parkinson's disease

A. Destée, M. Farrer, S. Lincoln, 1999, Neuroscience Letters.

Activation of autophagy through modulation of 5'-AMP-activated protein kinase protects pancreatic beta-cells from high glucose.

L. Olson, J. Goudreau, Eun-Kyoung Kim, 2010, The Biochemical journal.

Asiatic acid, a pentacyclic triterpene from Centella asiatica, is neuroprotective in a mouse model of focal cerebral ischemia

J. Goudreau, A. Majid, M. Kassab, 2009, Journal of neuroscience research.

Liquid chromatographic–electrospray mass spectrometric determination of 1-methyl-4-phenylpyridine (MPP+) in discrete regions of murine brain

J. Goudreau, A. Lehner, W. Rumbeiha, 2011, Toxicology mechanisms and methods.

Recovery of hypothalamic tuberoinfundibular dopamine neurons from acute toxicant exposure is dependent upon protein synthesis and associated with an increase in parkin and ubiquitin carboxy-terminal hydrolase-L1 expression.

J. Goudreau, M. Huebner, S. S. Pappas, 2012, Neurotoxicology.

Comparison of the D2 Receptor Regulation and Neurotoxicant Susceptibility of Nigrostriatal Dopamine Neurons in Wild-Type and CB1/CB2 Receptor Knockout Mice

J. Goudreau, A. Lehner, N. Kaminski, 2012, Journal of Neuroimmune Pharmacology.

Heterozygous VPS13A and PARK2 Mutations in a Patient with Parkinsonism and Seizures

R. Albin, J. Goudreau, W. Dauer, 2021, Case Reports in Neurology.

The role of de novo catecholamine synthesis in mediating methylmercury-induced vesicular dopamine release from rat pheochromocytoma (PC12) cells.

J. Goudreau, K. Lookingland, W. Atchison, 2013, Toxicological sciences : an official journal of the Society of Toxicology.

Methylmercury impairs canonical dopamine metabolism in rat undifferentiated pheochromocytoma (PC12) cells by indirect inhibition of aldehyde dehydrogenase.

J. Goudreau, K. Lookingland, W. Atchison, 2015, Toxicological sciences : an official journal of the Society of Toxicology.

Reduced Noradrenergic Signaling in the Spleen Capsule in the Absence of CB1 and CB2 Cannabinoid Receptors

J. Goudreau, D. Fried, J. Galligan, 2016, Journal of Neuroimmune Pharmacology.

5HT2 receptors mediate the effects of stress on the activity of periventricular hypophysial dopaminergic neurons and the secretion of alpha-melanocyte-stimulating hormone.

J. Goudreau, J. Manzanares, K. Lookingland, 1993, The Journal of pharmacology and experimental therapeutics.

Enhanced Humoral Immunity in Mice Lacking CB1 and CB2 Receptors (Cnr1−/−/Cnr2−/− Mice) is not Due to Increased Splenic Noradrenergic Neuronal Activity

J. Goudreau, Barbara L F Kaplan, K. Lookingland, 2014, Journal of Neuroimmune Pharmacology.

Neurochemical evidence that 5-hydroxytryptaminergic neurons tonically inhibit noradrenergic neurons terminating in the hypothalamus

K. E. Moore, J. Goudreau, K. Lookingland, 1993, Brain Research.

BDNF rs10501087, rs1491850 and rs11030094 polymorphisms associated with delayed progression in early-stage Parkinson's disease

J. Goudreau, P. Auinger, C. Kemp, 2022, Frontiers in Neurology.

Executive function in Parkinson’s disease: contributions of the dorsal frontostriatal pathways to action and motivation

M. Delgado, J. Goudreau, S. Ravizza, 2012, Cognitive, affective & behavioral neuroscience.

Autonomic and electrocardiographic findings in Parkinson's disease

R. Freeman, S. Luo, M. Aminoff, 2017, Autonomic Neuroscience.

Longer Duration of MAO-B Inhibitor Exposure is Associated with Less Clinical Decline in Parkinson's Disease: An Analysis of NET-PD LS1.

C. Christine, M. Aminoff, R. Zweig, 2017, Journal of Parkinson's disease.

Substrate‐mediated enhancement of phosphorylated tyrosine hydroxylase in nigrostriatal dopamine neurons: evidence for a role of α‐synuclein

J. Goudreau, K. Lookingland, B. Behrouz, 2006, Journal of neurochemistry.

Evidence that hypothalamic periventricular dopamine neurons innervate the intermediate lobe of the rat pituitary.

K. E. Moore, J. Goudreau, S. Lindley, 1992, Neuroendocrinology.

Mutations in SLC20A2 are a major cause of familial idiopathic basal ganglia calcification

D. Geschwind, P. Mazzoni, P. Svenningsson, 2013, neurogenetics.

Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression: The SURE-PD3 Randomized Clinical Trial.

D. Mozaffarian, Z. Mari, H. Shill, 2021, JAMA.

GSK-3β dysregulation contributes to parkinson’s-like pathophysiology with associated region-specific phosphorylation and accumulation of tau and α-synuclein

J. Goudreau, A. Sidhu, T. Steckler, 2014, Cell Death and Differentiation.

FosB and ΔFosB expression in brain regions containing differentially susceptible dopamine neurons following acute neurotoxicant exposure

Joseph R. Patterson, J. Goudreau, K. Lookingland, 2016, Brain Research.

Alpha‐Synuclein induces hyperphosphorylation of Tau in the MPTP model of Parkinsonism

J. Goudreau, T. Duka, A. Sidhu, 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Sustained resistance to acute MPTP toxicity by hypothalamic dopamine neurons following chronic neurotoxicant exposure is associated with sustained up-regulation of parkin protein.

J. Goudreau, K. Lookingland, Ki Yong Lee, 2013, Neurotoxicology.

Mice lacking alpha-synuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration.

J. Goudreau, K. Lookingland, B. Behrouz, 2004, Neurotoxicology.

Asiatic Acid Attenuates Infarct Volume, Mitochondrial Dysfunction, and Matrix Metalloproteinase-9 Induction After Focal Cerebral Ischemia

J. Goudreau, A. Majid, M. Kassab, 2012, Stroke.

Enhanced Humoral Immunity in Mice Lacking CB1 and CB2 Receptors (Cnr1−/−/Cnr2−/− Mice) is not Due to Increased Splenic Noradrenergic Neuronal Activity

J. Goudreau, K. Lookingland, R. Crawford, 2014, Journal of Neuroimmune Pharmacology.

Neonatal androgen‐dependent sex differences in lumbar spinal cord dopamine concentrations and the number of A11 diencephalospinal dopamine neurons

J. Goudreau, S. Breedlove, S. S. Pappas, 2010, The Journal of comparative neurology.

Comparison of the structure, function and autophagic maintenance of mitochondria in nigrostriatal and tuberoinfundibular dopamine neurons

Joseph R. Patterson, J. Goudreau, B. Winner, 2015, Brain Research.

The role of parkin in the differential susceptibility of tuberoinfundibular and nigrostriatal dopamine neurons to acute toxicant exposure.

J. Goudreau, F. Manfredsson, K. Lookingland, 2015, Neurotoxicology.

Autophagic Death of Adult Hippocampal Neural Stem Cells Following Insulin Withdrawal

J. Goudreau, Eun-Kyoung Kim, Heuiran Lee, 2008, Stem cells.

Disruption of FR-40 by 5-HT agonists. II. Effects of chronic phenelzine or isocarboxazid

J. Goudreau, R. Rech, D. Mackenzie-Taylor, 1989, Pharmacology Biochemistry and Behavior.

Pioglitazone in early Parkinson ' s disease : a phase 2 , multicentre , double-blind , randomised trial NINDS Exploratory Trials in Parkinson Disease ( NET-PD ) FS-ZONE Investigators

R. Pahwa, J. Carter, R. Zweig, 2017 .

Unique responses to mitochondrial complex I inhibition in tuberoinfundibular dopamine neurons may impart resistance to toxic insult

J. Goudreau, K. Lookingland, B. Behrouz, 2007, Neuroscience.

Metabolism of Dopamine in Nucleus Accumbens Astrocytes Is Preserved in Aged Mice Exposed to MPTP

J. Goudreau, B. Winner, K. Lookingland, 2017, Front. Aging Neurosci..

Case‐Control study of dopamine transporter‐1, monoamine oxidase‐B, and catechol‐O‐methyl transferase polymorphisms in Parkinson's disease

M. Farrer, D. Maraganore, T. Lesnick, 2002, Movement disorders : official journal of the Movement Disorder Society.

5-Hydroxytryptamine2 receptor-mediated regulation of periventricular-hypophysial dopaminergic neuronal activity and the secretion of alpha-melanocyte-stimulating hormone.

J. Goudreau, K. Lookingland, K. Moore, 1994, Journal of Pharmacology and Experimental Therapeutics.

Critical appraisal of the recent US FDA approval for earlier DBS intervention

J. Goudreau, L. Cabrera, C. Sidiropoulos, 2018, Neurology.

Bdnf variant is associated with milder motor symptom severity in early-stage Parkinson's disease.

J. Goudreau, P. Auinger, C. Kemp, 2018, Parkinsonism & related disorders.

Insulin withdrawal-induced cell death in adult hippocampal neural stem cells as a model of autophagic cell death

J. Goudreau, Eun-Kyoung Kim, K. Lookingland, 2009, Autophagy.

Amyloidosis presenting with intractable epistaxis and multiple cranial neuropathies.

J. Goudreau, D. Dodick, M. Gertz, 2000, Neurology.

Medical management of advanced Parkinson's disease.

J. Goudreau, 2006, Clinics in geriatric medicine.

Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease.

J. Goudreau, D. Kaufman, Alex F. Chen, 2005, Brain research. Molecular brain research.

Pose and Optical Flow Fusion (POFF) for accurate tremor detection and quantification

Mehmet Akif Alper, John L. Goudreau, Morris Daniel, 2020 .

GABAergic regulation of tuberoinfundibular dopaminergic neurons in the male rat

K. E. Moore, J. Goudreau, K. Lookingland, 1994, Brain Research.

Comparison of the D2 Receptor Regulation and Neurotoxicant Susceptibility of Nigrostriatal Dopamine Neurons in Wild-Type and CB1/CB2 Receptor Knockout Mice

J. Goudreau, A. Lehner, N. Kaminski, 2012, Journal of Neuroimmune Pharmacology.

A call for transparent reporting to optimize the predictive value of preclinical research

S. Lazic, O. Steward, Story C. Landis, 2012, Nature.

Autophagic Death of Adult Hippocampal Neural Stem Cells Following Insulin Withdrawal

J. Goudreau, Eun-Kyoung Kim, Heuiran Lee, 2008, Stem cells.

Executive function in Parkinson’s disease: contributions of the dorsal frontostriatal pathways to action and motivation

M. Delgado, J. Goudreau, S. Ravizza, 2011, Cognitive, Affective, & Behavioral Neuroscience.

Asiatic Acid Attenuates Infarct Volume, Mitochondrial Dysfunction, and Matrix Metalloproteinase-9 Induction After Focal Cerebral Ischemia

J. Goudreau, A. Majid, M. Kassab, 2012, Stroke.

Autonomic and electrocardiographic findings in Parkinson's disease

R. Freeman, S. Luo, M. Aminoff, 2017, Autonomic Neuroscience.

gamma-Aminobutyric acid receptor-mediated regulation of periventricular-hypophysial dopaminergic neurons: possible role in mediating stress- and 5-hydroxytryptamine-induced decreases in neuronal activity.

K. E. Moore, J. Goudreau, K. Lookingland, 1994, The Journal of pharmacology and experimental therapeutics.